The U.S. Supreme Court ruled Monday it will not take up an appeal from a group of drug makers attempting to block negotiations for lower drug prices.

The Supreme Court has rejected appeals from pharmaceutical companies that object to negotiating Medicare drug prices with the federal government.

Pharmaceutical companies are trying to prevent Medicare from negotiating discounts for drugs. Their legal challenges have been unsuccessful.